Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Monfardini

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
European Journal of Cancer & Clinical Oncology|February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)M van Glabbeke, J Renard, H M Pinedo, et al.
AIDS (London, England)|May 1, 1989
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 casesE Vaccher, U Tirelli, A Lazzarin, et al.
AIDS (London, England)|July 1, 1989
Unusual malignant tumours in 49 patients with HIV infectionS Monfardini, E Vaccher, G Pizzocaro, et al.
Leukemia|May 1, 1993
5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromesV Zagonel, G Lo Re, G Marotta, et al.
Haematologica|November 1, 1987
Comparison of presenting clinical and laboratory findings of patients with persistent generalized lymphadenopathy (PGL) syndrome and malignant lymphoma (ML)U Tirelli, E Vaccher, D Serraino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancerM O Nicoletto, R Padrini, E Ferrazzi, et al.
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Cancer Detection and Prevention|January 1, 1988
Clinical and laboratory findings at presentation in persistent generalized lymphadenopathy vs malignant lymphomaV Zagonel, U Tirelli, E Vaccher, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
European Journal of Cancer & Clinical Oncology|February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)M van Glabbeke, J Renard, H M Pinedo, et al.
AIDS (London, England)|May 1, 1989
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 casesE Vaccher, U Tirelli, A Lazzarin, et al.
AIDS (London, England)|July 1, 1989
Unusual malignant tumours in 49 patients with HIV infectionS Monfardini, E Vaccher, G Pizzocaro, et al.
Leukemia|May 1, 1993
5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromesV Zagonel, G Lo Re, G Marotta, et al.
Haematologica|November 1, 1987
Comparison of presenting clinical and laboratory findings of patients with persistent generalized lymphadenopathy (PGL) syndrome and malignant lymphoma (ML)U Tirelli, E Vaccher, D Serraino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancerM O Nicoletto, R Padrini, E Ferrazzi, et al.
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Cancer Detection and Prevention|January 1, 1988
Clinical and laboratory findings at presentation in persistent generalized lymphadenopathy vs malignant lymphomaV Zagonel, U Tirelli, E Vaccher, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.
Pageof 25